clinical evolution of chronic renal patients with hiv infection in replacement therapy
Clicks: 237
ID: 260101
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
237 views
31 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #18 of 68 articles by views in demiryolu mühendisliği
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Patients on renal replacement therapy (RRT) infected with the human immunodeficiency virus (HIV) are a special group with growing interest. In order to study the epidemiological data of HIV+ patients on RRT in Spain, we collected individual information from 2004 to 2011 (period of use of highly active antiretroviral therapy [HAART]) in the Autonomous Communities of Andalusia, Aragon, Asturias, Catalonia, Valencia, Castilla la Mancha, Castilla León, Galicia, Madrid, La Rioja and the Basque Country, comprising 85% of the Spanish population. A total of 271 incident and 209 prevalent patients were analysed. They were compared with the remaining patients on RRT during the same period. The annual incidence was 0.8 patients per one million inhabitants, with a significant increase during the follow-up period. The proportion of prevalent HIV+ patients was 5.1 per 1000 patients on RRT (95% confidence interval [CI] 4.4–5.8). Although glomerular diseases constituted the majority of cases (42%), diabetic nephropathy was the cause in 14% of patients. The nation-wide totals for these percentages were 13 and 25%, respectively. Compared to the total of patients in treatment, the risk of death was significantly higher in the HIV+ group: hazard ratio (HR) adjusted for age, sex and diabetes was 2.26 (95%CI 1.74–2.91). Hepatitis C coinfection increased the risk of death in the HIV+ group (HR 1.77; 95%CI 1.10–2.85). The probability of kidney transplantation in HIV+ was only 17% after 7 years, comparing with total RTT patients (HR 0.15; 95%CI: 0.10–0.24).
Despite the use of HAART, the incidence of HIV+ patients on dialysis has increased; their mortality still exceeds non-HIV patients, and they have a very low rate of transplantation. It is necessary to further our knowledge of this disease in order to improve results.
| Reference Key |
saracho2015nefrologaclinical
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Ramón Saracho;Eduardo Martín Escobar;Jordi Comas Farnés;Emma Arcos;Auxiliadora Mazuecos Blanca;Miguel Ángel Gentil Govantes;Pablo Castro de la Nuez;Óscar Zurriaga;Manuel Ferrer Alamar;Encarnación Bouzas Caamaño;Teresa García Falcón;José Portolés Pérez;José A. Herrero Calvo;Carlos Chamorro Jambrina;Íñigo Moina Eguren;María Teresa Rodrigo de Tomás;José María Abad Díez;José I. Sánchez Miret;Rafael Alvarez Lipe;Rafael Díaz Tejeiro;Inmaculada Moreno Alía;Marta Torres Guinea;Enma Huarte Loza;Marta Artamendi Larrañaga;Carlos Fernández Renedo;Raquel González Fernández;Emilio Sánchez Álvarez;Ramón Alonso de la Torre |
| Journal | demiryolu mühendisliği |
| Year | 2015 |
| DOI |
10.1016/j.nefroe.2015.11.004
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.